Comments
Commented by Stefan Feulner on August 5th, 2024 | 07:15 CEST
BYD, Globex Mining, Coinbase - New opportunities after the price storm
Weak labour market data from the US, which once again increased fears of a recession, the Intel shock, and the further escalation of the situation in the Middle East, put additional pressure on stock markets around the globe. The Dow Jones fell by just under 3% over the week, while Germany's leading index, the DAX, lost over 4.5% in the same period. The market's overall weakness meant that positive company reports took a back seat. This creates opportunities at a discounted level.
Read
Commented by André Will-Laudien on August 5th, 2024 | 07:00 CEST
In the fight against cancer - 100% performance possible: Bayer, Vidac Pharma, Evotec, BioNTech and CureVac
The FED is giving new hope to the Biotech sector with lower interest rates, which are expected to happen as early as September. This is important for the near future, as share prices are lagging dramatically behind the NASDAQ performance in 2024. However, if extensive research can be financed under more favourable conditions, this should also help the stock market prices recover. The business models contain some good news, and selection is now crucial. We assist in selecting attractive stocks and provide entry levels.
Read
Commented by Juliane Zielonka on August 2nd, 2024 | 06:30 CEST
Transformation in full swing: Altech, Volkswagen, and Bayer focus on new technologies and markets
Shortly after the grandiose Olympic opening ceremony, Paris showed us what it means to sit in the dark. One day after the opening ceremony, the inhabitants of the Seine were hit by a power outage. Speculation as to the cause ranges from a cyber attack to sabotage, similar to the recent arson attacks on the French rail network. But one thing is certain, it shows how fragile the power supply currently is. This is reason enough for Altech Advanced Materials to press ahead with the development of its stationary solid-state battery. A type of local battery power plant ensures a stable power supply, even with fluctuations in the grid due to wind and solar energy. The German company has another profitable development up its sleeve for the EV market. Volkswagen continues to focus on its electric vehicles and can look forward to increased sales in China. Nevertheless, the Wolfsburg-based company must make considerable savings to remain profitable. The results of the first half of the year provide deep insights. Additionally, for 27 million women in the US, ones battery can be figuratively "empty" at times. Fatigue, hot flashes, and nervousness are classic symptoms of menopause. 27 million is the market size of menopausal women that Bayer AG now aims to capture with a very special medication...
Read
Commented by Juliane Zielonka on August 1st, 2024 | 07:45 CEST
Commodities, Travel, Defense: Almonty, Lufthansa, and Rheinmetall in focus
Global tensions offer enormous potential for investors. Given the conflicts with China and Russia, the US urgently needs to reorganise its supply chains for defense raw materials. Almonty Industries, for example, is gaining strategic importance for the US defense industry with its Sangdong project in South Korea. Meanwhile, German airline Lufthansa is struggling with price pressure and rising costs. The management is aware of the challenges and continues to pursue its strict turnaround strategy. Investors should be prepared for profit warnings here. Despite Russian threats, defense contractor Rheinmetall is expanding in Eastern Europe, with new projects in Hungary and Ukraine. Where is an investment currently proving lucrative?
Read
Commented by Fabian Lorenz on August 1st, 2024 | 06:30 CEST
Evotec slashed, Bayer sued, and Cardiol Therapeutics share praised
Anyone speculating on a quick rebound for Evotec will be disappointed. At present, one can at most speak of a bottoming out. It is fitting that a renowned analyst has slashed his price target for the German biotech share. Or is it only half as bad? Analysts see massive upside potential for the shares of Cardiol Therapeutics. The share price has more than doubled in the current year and is currently consolidating. There is an exciting entry opportunity now that positive study results have fizzled out on the stock market. Bayer, on the other hand, simply cannot get out of the world's courtrooms. In the US, a new lawsuit has been filed against the Leverkusen-based company; in another case, a multi-million dollar payment must be made.
Read
Commented by Fabian Lorenz on July 31st, 2024 | 06:45 CEST
Nel, Bitcoin Group, VCI Global with Super Micro Computer: Shares on the verge of a mega rally?
The Nel share is driving not only investors to despair but also analysts. While some see 100% upside potential, others are advising investors to sell. And what is the Bitcoin Group doing? After tripling in value, the crypto exchange's share price has corrected significantly in recent weeks. Will the operating figures bring new momentum? VCI Global aims to benefit even more from the boom in artificial intelligence. To meet the demand for computing power, the Company, listed on the NASDAQ and in Frankfurt, plans to set up an AI data centre in Malaysia by mid-2025. Among its partners is the AI heavyweight Super Micro Computer, with chips likely to come from NVIDIA.
Read
Commented by André Will-Laudien on July 30th, 2024 | 07:00 CEST
Olympic turnaround expected: TUI and Lufthansa bombed out, dynaCERT on the move, and BayWa poised for a comeback!
When shares fall sharply, there are often fundamental reasons, but sometimes the story is misunderstood by investors, and both scenarios can occur simultaneously. In the case of the tourism shares TUI and Lufthansa, it is noticeable that the share prices are going nowhere in the middle of the holiday season. Are there still skeletons in the closet? BayWa is at least making some headway but is dangerously overindebted. The hydrogen specialist dynaCERT now has all the pieces of the puzzle together, and significant movement is expected soon. We provide deeper insights for your portfolio strategy.
Read
Commented by Armin Schulz on July 30th, 2024 | 06:45 CEST
thyssenkrupp, Globex Mining, Barrick Gold - Which share holds the most potential?
In the midst of a turbulent phase on the global markets, companies in the commodities sector are facing enormous challenges. Recent developments have increased volatility, as evidenced by the unexpectedly strong growth in China's commodity imports in July. Despite these positive signals, the market reaction has been subdued, partly due to negative indicators like the falling copper price. Copper serves as an early indicator of global economic strength. Investors eagerly await a potential rebound while market observers discuss the causes and future opportunities. Today, we will look at a steel, mining, and gold company to determine which one holds the most potential.
Read
Commented by Stefan Feulner on July 30th, 2024 | 06:30 CEST
Viking Therapeutics, Vidac Pharma, Merck KGaA - In the footsteps of Novo Nordisk
Drugs for the treatment of diabetes and obesity have helped the pharmaceuticals manufacturer Novo Nordisk to become the most valuable listed company in Europe. But the competition is not sleeping. Many promising biotechs are already presenting new preparations that could overtake the Danes in the long term. Young companies with the chance of the next blockbuster also have great potential in other areas, such as cancer research.
Read
Commented by Stefan Feulner on July 29th, 2024 | 06:45 CEST
Riot Platforms, Desert Gold Ventures, British American Tobacco with a bang
Summer is in its hot phase, and there is no sign that the global stock markets are cooling down. On the contrary, with the US election campaign entering a new round following Joe Biden's withdrawal, the presidential candidates are trying to mobilize voters. One target group that Donald Trump was able to win over at the weekend is that of crypto enthusiasts. In a fiery speech at Bitcoin 2024 in Nashville, he emphasized that Bitcoin would rise like never before under his presidency.
Read